281 related articles for article (PubMed ID: 16540030)
41. Prognostic importance of renal function in patients with early heart failure and mild left ventricular dysfunction.
Smilde TD; Hillege HL; Voors AA; Dunselman PH; Van Veldhuisen DJ
Am J Cardiol; 2004 Jul; 94(2):240-3. PubMed ID: 15246913
[TBL] [Abstract][Full Text] [Related]
42. Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality.
Tsagalis G; Akrivos T; Alevizaki M; Manios E; Stamatellopoulos K; Laggouranis A; Vemmos KN
Nephrol Dial Transplant; 2009 Jan; 24(1):194-200. PubMed ID: 18728156
[TBL] [Abstract][Full Text] [Related]
43. Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure.
van der Meer P; Lipsic E; Westenbrink BD; van de Wal RM; Schoemaker RG; Vellenga E; van Veldhuisen DJ; Voors AA; van Gilst WH
Circulation; 2005 Sep; 112(12):1743-7. PubMed ID: 16172283
[TBL] [Abstract][Full Text] [Related]
44. Cystatin C in acute heart failure without advanced renal impairment.
Naruse H; Ishii J; Kawai T; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Matsui S; Nomura M; Hishida H; Ozaki Y
Am J Med; 2009 Jun; 122(6):566-73. PubMed ID: 19393984
[TBL] [Abstract][Full Text] [Related]
45. Kidney function and mortality among patients with left ventricular systolic dysfunction.
Khan NA; Ma I; Thompson CR; Humphries K; Salem DN; Sarnak MJ; Levin A
J Am Soc Nephrol; 2006 Jan; 17(1):244-53. PubMed ID: 16291840
[TBL] [Abstract][Full Text] [Related]
46. Evolution of renal function during and after an episode of cardiac decompensation: results from the Italian survey on acute heart failure.
Tarantini L; Cioffi G; Gonzini L; Oliva F; Lucci D; Di Tano G; Maggioni AP; Tavazzi L;
J Cardiovasc Med (Hagerstown); 2010 Apr; 11(4):234-43. PubMed ID: 19858732
[TBL] [Abstract][Full Text] [Related]
47. Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.
Solomon SD; Rice MM; A Jablonski K; Jose P; Domanski M; Sabatine M; Gersh BJ; Rouleau J; Pfeffer MA; Braunwald E;
Circulation; 2006 Jul; 114(1):26-31. PubMed ID: 16801465
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of anemia in patients admitted to hospital with a primary diagnosis of congestive heart failure.
Wexler D; Silverberg D; Sheps D; Blum M; Keren G; Iaina A; Schwartz D
Int J Cardiol; 2004 Jul; 96(1):79-87. PubMed ID: 15203265
[TBL] [Abstract][Full Text] [Related]
49. A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction.
Brophy JM; Dagenais GR; McSherry F; Williford W; Yusuf S
Am J Med; 2004 Mar; 116(5):300-4. PubMed ID: 14984814
[TBL] [Abstract][Full Text] [Related]
50. Prognostic effect of renal dysfunction after ST-segment elevation myocardial infarction with and without heart failure.
Bertomeu-Gonzalez V; Núñez J; Núñez E; Fácila L; Sanchis J; Bodí V; Pellicer M; Bosch MJ; Martínez A; Chorro FJ; Llàcer A
Int J Cardiol; 2006 Sep; 112(2):159-65. PubMed ID: 16290104
[TBL] [Abstract][Full Text] [Related]
51. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study.
Klein L; O'Connor CM; Leimberger JD; Gattis-Stough W; Piña IL; Felker GM; Adams KF; Califf RM; Gheorghiade M;
Circulation; 2005 May; 111(19):2454-60. PubMed ID: 15867182
[TBL] [Abstract][Full Text] [Related]
52. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure.
Siirilä-Waris K; Lassus J; Melin J; Peuhkurinen K; Nieminen MS; Harjola VP;
Eur Heart J; 2006 Dec; 27(24):3011-7. PubMed ID: 17127708
[TBL] [Abstract][Full Text] [Related]
53. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening.
Halbesma N; Kuiken DS; Brantsma AH; Bakker SJ; Wetzels JF; De Zeeuw D; De Jong PE; Gansevoort RT
J Am Soc Nephrol; 2006 Sep; 17(9):2582-90. PubMed ID: 16899519
[TBL] [Abstract][Full Text] [Related]
54. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
Klein L; Massie BM; Leimberger JD; O'Connor CM; Piña IL; Adams KF; Califf RM; Gheorghiade M;
Circ Heart Fail; 2008 May; 1(1):25-33. PubMed ID: 19808267
[TBL] [Abstract][Full Text] [Related]
55. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice.
Barrios V; Escobar C; Murga N; de Pablo C; Bertomeu V; Calderón A; Echarri R
J Hypertens; 2008 Nov; 26(11):2230-5. PubMed ID: 18854765
[TBL] [Abstract][Full Text] [Related]
56. Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival.
Smilde TD; Hillege HL; Navis G; Boomsma F; de Zeeuw D; van Veldhuisen DJ
Am Heart J; 2004 Jul; 148(1):165-72. PubMed ID: 15215807
[TBL] [Abstract][Full Text] [Related]
57. Serum creatinine values underestimate surgical risk.
Dourado R; Queiroz e Melo J; Abecasis J; Ferreira A; Barata JD; Rebocho MJ; Abecasis M; Ferreira M; Neves JP
Rev Port Cardiol; 2009 Mar; 28(3):269-78. PubMed ID: 19480310
[TBL] [Abstract][Full Text] [Related]
58. Prognostic factors and predictors of in-hospital mortality of patients with heart failure with preserved left ventricular ejection fraction.
Pérez de Isla L; Zamorano J; Hernández N; Contreras L; Rodrigo JL; Almería C; Aubele AL; Mataix L; Macaya C
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1011-5. PubMed ID: 18799963
[TBL] [Abstract][Full Text] [Related]
59. Renal dysfunction predicts long-term mortality in patients with lower extremity arterial disease.
Pasqualini L; Schillaci G; Pirro M; Vaudo G; Siepi D; Innocente S; Ciuffetti G; Mannarino E
J Intern Med; 2007 Dec; 262(6):668-77. PubMed ID: 17908164
[TBL] [Abstract][Full Text] [Related]
60. Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials.
Phillips CO; Kashani A; Ko DK; Francis G; Krumholz HM
Arch Intern Med; 2007 Oct; 167(18):1930-6. PubMed ID: 17923591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
